| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Cardiff Oncology Inc (NASDAQ: CRDF)
CRDF Technical Analysis
5
| As on 9th Jun 2023 CRDF STOCK Price closed @ 1.62 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 2.55 & Strong Sell for SHORT-TERM with Stoploss of 4.40 we also expect STOCK to react on Following IMPORTANT LEVELS. |
CRDFSTOCK Price
| Open | 1.65 | Change | Price | % |
| High | 1.66 | 1 Day | -0.01 | -0.61 |
| Low | 1.61 | 1 Week | -0.04 | -2.41 |
| Close | 1.62 | 1 Month | 0.12 | 8.00 |
| Volume | 59500 | 1 Year | -4.52 | -73.62 |
| 52 Week High 7.25 | 52 Week Low 1.17 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| CRDF Daily Charts |
CRDF Intraday Charts |
Whats New @ Bazaartrend |
CRDF Free Analysis |
|
|
CRDF Important Levels Intraday
| RESISTANCE | 1.72 |
| RESISTANCE | 1.69 |
| RESISTANCE | 1.67 |
| RESISTANCE | 1.65 |
| SUPPORT | 1.59 |
| SUPPORT | 1.57 |
| SUPPORT | 1.55 |
| SUPPORT | 1.52 |
CRDF Forecast May 2024
| 4th UP Forecast | 9.93 |
| 3rd UP Forecast | 7.26 |
| 2nd UP Forecast | 5.62 |
| 1st UP Forecast | 3.97 |
| 1st DOWN Forecast | -0.73 |
| 2nd DOWN Forecast | -2.38 |
| 3rd DOWN Forecast | -4.02 |
| 4th DOWN Forecast | -6.69 |
CRDF Weekly Forecast
| 4th UP Forecast | 3.08 |
| 3rd UP Forecast | 2.61 |
| 2nd UP Forecast | 2.32 |
| 1st UP Forecast | 2.03 |
| 1st DOWN Forecast | 1.21 |
| 2nd DOWN Forecast | 0.92 |
| 3rd DOWN Forecast | 0.63 |
| 4th DOWN Forecast | 0.16 |
CRDF Forecast2024
| 4th UP Forecast | 13.55 |
| 3rd UP Forecast | 9.72 |
| 2nd UP Forecast | 7.36 |
| 1st UP Forecast | 4.99 |
| 1st DOWN Forecast | -1.75 |
| 2nd DOWN Forecast | -4.12 |
| 3rd DOWN Forecast | -6.48 |
| 4th DOWN Forecast | -10.31 |
Cardiff Oncology Inc ( NASDAQ USA Symbol : CRDF )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
CRDF Business Profile
Cardiff Oncology, Inc., a clinical-stage biotechnology company, develops drugs for the treatment of cancer. Its lead drug candidate is onvansertib, a Polo-like Kinase 1 selective adenosine triphosphate competitive inhibitor that is in Phase Ib/II clinical trial in acute myeloid leukemia (AML); has completed a Phase I clinical trial in advanced solid tumors; and Phase Ib/II clinical trial for metastatic colorectal cancer in combination with FOLFIRI and Avastin. The company's onvansertib is also in Phase II clinical trial in combination with Zytiga for metastatic castration-resistant prostate cancer. In addition, it develops therapeutics, such as belinostat (Beleodaq); quizartinib (AC220), a development stage FLT3 inhibitor; and bortezomib (Velcade) for the treatment of leukemias, lymphomas, and solid tumor cancers. The company primarily serves pharmaceutical companies. Cardiff Oncology, Inc. has a research collaboration with Nektar Therapeutics for the treatment of colorectal cancer. The company was formerly known as Trovagene, Inc. and changed its name to Cardiff Oncology, Inc. in May 2020. Cardiff Oncology, Inc. was incorporated in 1999 and is headquartered in San Diego, California. Address: 11055 Flintkote Avenue, San Diego, CA, United States, 92121
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service